Opus Genetics, Inc. (IRD)

NASDAQ: IRD · Real-Time Price · USD

3.800

-0.310 (-7.54%)

At close: Aug 26, 2026, 4:00 PM EDT

3.800

0.00 (0.00%)

After-hours: Aug 26, 2026, 4:00 PM EDT

Opus Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	88.81	45.09	30.32	50.5	42.63	24.53
Short-Term Investments	-	-	0	0.02	0.05	0.22
Cash & Short-Term Investments	88.81	45.09	30.32	50.52	42.68	24.75
Cash Growth	173.87%	48.70%	-39.97%	18.35%	72.44%	50.94%
Accounts Receivable	1.46	3.17	5.77	2.33	4.85	-
Receivables	1.46	3.17	5.77	2.33	4.85	-
Prepaid Expenses	2.43	1.79	0.52	1.1	1.37	1.24
Other Current Assets	-	-	-	-	0.08	0.07
Total Current Assets	92.7	50.04	36.61	53.95	48.99	26.07
Property, Plant & Equipment	0.17	0.2	0.25	-	0.01	0.01
Total Assets	92.97	50.24	36.86	53.95	48.99	26.08

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.88	3.29	3.15	2.15	1.07	1.58
Accrued Expenses	5.7	4.47	7.54	1.82	1.37	1.73
Short-Term Debt	-	-	-	-	-	0.54
Current Income Taxes Payable	-	-	-	-	0.32	-
Other Current Liabilities	0.02	0.02	0.61	0.07	-	-
Total Current Liabilities	7.61	7.78	11.3	4.04	2.75	3.86
Long-Term Debt	36.2	1.13	-	-	-	-
Other Long-Term Liabilities	62.15	25.99	-	-	-	-
Total Liabilities	105.95	34.9	11.3	4.04	2.75	3.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	249.23	203.93	145.72	131.37	117.72	111.59
Retained Earnings	-262.22	-188.59	-139	-81.47	-71.48	-89.37
Total Common Equity	-12.99	15.35	6.72	49.91	46.24	22.22
Shareholders' Equity	-12.99	15.35	25.57	49.91	46.24	22.22
Total Liabilities & Equity	92.97	50.24	36.86	53.95	48.99	26.08

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	36.2	1.13	-	-	-	0.54
Net Cash (Debt)	52.61	43.96	30.32	50.52	42.68	24.22
Net Cash Growth	67.39%	44.98%	-39.97%	18.35%	76.27%	47.66%
Net Cash Per Share	0.63	0.71	1.14	2.34	2.07	1.63
Filing Date Shares Outstanding	83.2	71.15	45.48	24.81	20.95	18.99
Total Common Shares Outstanding	82.65	69.89	31.57	23.98	20.86	18.85
Working Capital	85.09	42.26	25.32	49.91	46.23	22.21
Book Value Per Share	-0.16	0.22	0.21	2.08	2.22	1.18
Tangible Book Value	-12.99	15.35	6.72	49.91	46.24	22.22
Tangible Book Value Per Share	-0.16	0.22	0.21	2.08	2.22	1.18
Machinery	-	-	-	-	0.03	0.03

SEC Filings: 10-K · 10-Q